Press release
Angiosarcoma Treatment Market: 2024 Global Future Scope, Ageing Population, Application, Industry Growth, Demand, Region, Competitive Analysis and Forecast 2031 | Novartis AG, Bayer AG, Sanofi
Angiosarcoma Treatment Market || 2024-2031
DataM Intelligence has published a new research report on "Angiosarcoma Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. . The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/angiosarcoma-treatment-market
The Angiosarcoma Treatment market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Angiosarcoma most commonly affects areas like the skin, breast, liver, and spleen. The global angiosarcoma treatment market has seen notable growth, driven by the adoption of targeted therapies, such as tyrosine kinase inhibitors (e.g., pazopanib, regorafenib) that target vascular endothelial growth factor. Increased clinical trials, collaborations, and ongoing research contribute to future market expansion. North America, particularly the U.S. and Canada, has experienced rising demand due to technological advancements. Major players like Amgen Inc., Eli Lilly, and Genentech Inc. are key contributors to this market.
Key Developments:
In September 2020, data presented at the ESMO Virtual Congress from a phase 2 basket study revealed that pembrolizumab monotherapy improved progression-free survival (PFS) in certain rare sarcoma subtypes, including epithelioid sarcoma, angiosarcoma, and chondrosarcoma.
In December 2020, clinician-scientists from the National Cancer Centre Singapore (NCCS), along with global collaborators, discovered that angiosarcomas possess distinct genomic and immune profiles. This breakthrough enables the classification of angiosarcomas into three subtypes, allowing for more personalized treatment approaches.
Forecast Growth Projected:
The Global Angiosarcoma Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Angiosarcoma Treatment Market:
Novartis AG, Bayer AG, Sanofi, Amgen Inc., Eli Lilly and Company, Genentech Inc., Janssen Pharmaceuticals, AbbVie Inc, Bausch Health, GlaxoSmithKline Plc.
Segment Covered in the Angiosarcoma Treatment Market:
By Type: Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma
By Treatment: Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others
By End Users: Hospitals, Clinics, Ambulatory Surgical Centers, Others
Regional Analysis:
The global Angiosarcoma Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/angiosarcoma-treatment-market
Regional Analysis:
The global Angiosarcoma Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Angiosarcoma Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Angiosarcoma Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Angiosarcoma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/angiosarcoma-treatment-market
For Affiliate Market: Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
The research study aims to address the following key questions:
➡What is the expected growth rate of the Angiosarcoma Treatment Market during the forecast period of 2031?
➡What key factors are driving the Angiosarcoma Treatment Market across various regions?
➡Who are the leading vendors in the Angiosarcoma Treatment industry, and what strategies contribute to their success?
➡What is the anticipated market scope for the projected period?
➡What major trends are influencing the industry's growth in the coming years?
➡What challenges does the Angiosarcoma Treatment Market face?
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiosarcoma Treatment Market: 2024 Global Future Scope, Ageing Population, Application, Industry Growth, Demand, Region, Competitive Analysis and Forecast 2031 | Novartis AG, Bayer AG, Sanofi here
News-ID: 3668944 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Postbiotics Food Supplements Market 2025 | Gains Momentum with Regulatory Push a …
The Postbiotics Food Supplements Market is entering a pivotal growth phase, with strong developments in the U.S. and Japan shaping the global trajectory.
According to DataM Intelligence, the global market for postbiotic food supplements was valued at USD $ 10.8 million in 2023 and is projected to reach USD $ 27.3 million by 2031, growing at a CAGR of 11.2%. The U.S. and Japan remain the two most influential markets…
Uranium Market Drivers: Clean Energy Shift & Nuclear Reactor Growth | Top Most K …
Global Uranium Market size reached US$ 9.30 billion in 2024 and is expected to reach US$ 13.59 billion by 2032, growing with a CAGR of 4.86% during the forecast period 2025-2032.
The Uranium Market Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings,…
Innovative High Altitude Platforms: Stratospheric Balloons, Airships & UAV Techn …
Global High Altitude Platform Market reached US$ 1.64 billion in 2024 and is expected to reach US$ 3.13 billion by 2032, growing with a CAGR of 8.40% during the forecast period 2025-2032.
The High Altitude Platform Market Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions…
IoT Devices Market Drivers: Data Analytics, Connectivity & Intelligent Infrastru …
Global IoT devices market size reached US$ 130.88 billion in 2024 and is expected to reach US$ 522.79 billion by 2032, growing with a CAGR of 18.90% during the forecast period 2025-2032.
The IoT Devices Market Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including…
More Releases for Angiosarcoma
Cutaneous Angiosarcoma Market New Product Development & Latest Trends
Introduction
Cutaneous angiosarcoma is a rare and aggressive malignancy that originates from endothelial cells lining blood vessels and lymphatics in the skin. Though it represents a small fraction of soft-tissue sarcomas, its high recurrence rates, metastatic potential, and poor prognosis make it one of the most challenging cancers to manage. The condition most frequently affects elderly patients and is often associated with chronic lymphedema, prior radiation exposure, or immunosuppression.
Traditional management has…
Angiosarcoma Treatment Market Growth Trends: Regional Analysis, Segmentation, Ap …
The Angiosarcoma Treatment Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/angiosarcoma-treatment-market
What is the projected…
Miniaturized sensors to take the Angiosarcoma Treatment Market by storm
With the established fact that AI technology would be helping the medical professionals in execution of daily tasks, the other side stating that hackers could also exploit this technology for attacking medical systems and stealing protected healthcare information can't be ignored. Medical cybersecurity professionals will actually have an uphill task herein. Genetics is also being used in treatment. This would be the direction Angiosarcoma Treatment Market would be going to…
Angiosarcoma Treatment Market Significantly Stepping towards the Success Till 20 …
Sarcoma is a rare type of cancer that occurs when mesenchymal cells change. Sarcoma is a common type of cancer of the bone, fats, skin, soft tissues, and breast, and angiosarcoma is a rare type of soft tissue cancer. Angiosarcoma is cancer that starts in the cells of blood arteries and can spread to any part of the body. The global Angiosarcoma Treatment market size is projected to reach US$…
Angiosarcoma gets orphan drug as Propranolol by EC
European Commission has granted Orphan Drug Designation to Propranolol for the treatment of Angiosarcoma, a lethal form of soft tissue sarcoma. Propranolol has been commonly used in the treatment of high blood pressure.
The EMA’s designation of orphan status is granted to encourage new developments and therapies for rare diseases and disorders. Orphan status can be granted to those diseases that are rare. These incentives include protocol assistance, i.e. scientific advice…
Steadily Increasing Prevalence of the Disease Drives the Global Angiosarcomas Tr …
Rare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, such as bone, breast, skin, fats and soft tissues. One such rare type of soft tissue tumor is called as Angiosarcomas. This tumor begins to grow in the cells of a blood vessels and can occur in any part of body. Angiosarcoma tumors involve rapidly proliferating cancerous…
